跳至主要内容
临床试验/NCT05225714
NCT05225714已完成不适用

Assessment of Performance of Silkam® Suture Material for Skin Closure - a Prospective, Single Center, Single Arm, Observational Study in Daily Practice

Aesculap AG1 个研究点 分布在 1 个国家目标入组 161 人开始时间: 2022年7月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Aesculap AG
入组人数
161
试验地点
1
主要终点
Surgical Site Infection Rate

研究概览

简要总结

Assessment of performance of Silkam® suture material for skin closure. A prospective, single center, single arm, observational study in daily practice.

详细描述

The prospective, monocentric, single-arm, observational Post Market Clinical Follow-Up (PMCF) study is done to continue to evaluate the safety and performance of Silkam® suture material for skin closure under clinical routine. Safety and effectiveness parameters commonly used in skin closure are to be used to evaluate the performance of the suture material.

The aim of this Non Interventional Study is to collect systematically and proactively different clinical parameters regarding safety, effectiveness and performance of Silkam® suture material under the daily routine clinical practice when used for skin closure as intended.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Adult and paediatric patients undergoing skin closure using Silkam® as suture material.
  • Written informed consent regarding the data collection for the PMCF study.

排除标准

  • Pregnancy
  • Visible dirty wounds
  • Patients taking medication that might affect wound healing
  • Patients with hypersensitivity or allergy to the suture material

结局指标

主要结局

Surgical Site Infection Rate

时间窗: at suture removal approx. 10 ± 5 days postoperative

A surgical site infection is an infection that occurs after surgery in the part of the body where the surgery took place. Surgical site infections can sometimes be superficial infections involving the skin only (A1). Other surgical site infections are more serious and can involve tissues under the skin, organs, or implanted material. (A2)

次要结局

  • Pain: Visual Analogue Scale (VAS)(at suture removal approx. 10 ± 5 days postoperative)
  • Cosmetic Outcome(at suture removal approx. 10 ± 5 days postoperative)
  • Assessment of the handling of the suture material(intraoperative)
  • Adverse Event Rate(at suture removal approx. 10 ± 5 days postoperative)
  • Individual A1 Surgical Site Infection Rate(at suture removal approx. 10 ± 5 days postoperative)
  • Individual A2 Surgical Site Infection Rate(at suture removal approx. 10 ± 5 days postoperative)
  • Satisfaction of the patient: Visual Analogue Scale (VAS)(at suture removal approx. 10 ± 5 days postoperative)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验